PLASMA PROTEIN THERAPEUTICS ASSOCIATION for PLASMA PROTEIN THERAPEUTICS ASSOCIATION
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 18, 2017 | $50,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Dec 14, 2017 | $130,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Protecting Americans from Tax Hikes (PATH) Act, sections pertaining to the Research and Development tax credit, and the Orphan Drug Tax Credit.
Foreign entity interest: Grifols, S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER | — |
| THOMAS B LILBURN | — |
| BRENNA RAINES | — |
| KIMBERLY SEROTA | — |
| CHASE THOMAS | — |
Health Issues HCR
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products.
Foreign entity interest: GRIFOLS S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER | — |
| THOMAS B LILBURN | — |
| BRENNA RAINES | — |
| KIMBERLY SEROTA | — |
| CHASE THOMAS | — |
Medicare/Medicaid MMM
The Affordable Care Act, provisions relating to essential health benefits and patient protections. HR 1628, The American Health Care Act, sections pertaining to essential health benefits, lifetime caps and affordability. Senate Better Care Reconciliation Act sections relating to essential health benefits, lifetime caps and affordability. HR 34, 21st Century Cures, relating to payment of pharmacy services for home infusion drugs in DME products. Legislation to extend the duration of the IVIG demonstration project.HR 3178, the Medicare Part B Improvement Act of 2017, provisions relating to the Medicare IVIG Demonstration Extension Act of 2017 and the Medicare Part B Infusion Services Temporary Transitional Payment Act. S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 HR 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act, sections pertaining to payment of pharmacy fees. H.R. 3823, the Disaster Tax Relief and Airport and Airway Extension Act of 2017 - Section 302 including the extension of the Medicare Patient Intravenous Immunoglobin (IVIG) Access Demonstration Project.
Foreign entity interest: GRIFOLS S.A.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE BIRKOFER | — |
| THOMAS B LILBURN | — |
| BRENNA RAINES | — |
| KIMBERLY SEROTA | — |
| CHASE THOMAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.